Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography

Citation
M. Bouley et al., Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography, THER DRUG M, 23(1), 2001, pp. 56-60
Citations number
19
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
THERAPEUTIC DRUG MONITORING
ISSN journal
01634356 → ACNP
Volume
23
Issue
1
Year of publication
2001
Pages
56 - 60
Database
ISI
SICI code
0163-4356(200102)23:1<56:SARMFT>2.0.ZU;2-4
Abstract
A rapid, sensitive, and specific liquid chromatography method for the simul taneous determination of four protease inhibitors (indinavir, nelfinavir, r itonavir, and saquinavir) in human plasma is described. After a liquid-liqu id extraction with terbutyl methyl ether and a sequential washing of the re constituted sample with hexane, protease inhibitors are separated on a phen yl column using a simple binary mobile phase of ammonium acetate buffer:ace tonitrile (48:52) (pH = 7.5) with an ultraviolet detection at 260 nm. The s tandard curves are linear in the range 0.025-1 mug/mL for saquinavir. 0.1-4 mug/mL for indinavir and nelfinavir, and 0.25-10 mug/mL for ritonavir, wit h an average recovery ranging from 79% to 99%, and with both low interday a nd intraday coefficients of variation (<15%). This assay is simple, rapid ( 15-minute interval between runs). and useful for therapeutic monitoring of the protease inhibitors on a routine basis.